Analysts expect Enanta Pharma to report an earnings per share (EPS) of $-0.74.
Investors in Enanta Pharma are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Performance in Previous Earnings
During the last quarter, the company reported an EPS beat by $0.19, leading to a 3.59% drop in the share price on the subsequent day.
Here's a look at Enanta Pharma's past performance and the resulting price change:
Quarter
Q4 2025
Q3 2025
Q2 2025
Q1 2025
EPS Estimate
-1.06
-1.03
-1.46
-1.35
EPS Actual
-0.87
-0.85
-1.06
-1.05
Price Change %
-4.00
6.00
-6.00
14.00
Market Performance of Enanta Pharma's Stock
Shares of Enanta Pharma were trading at $12.97 as of February 05. Over the last 52-week period, shares are up 174.08%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
Analyst Opinions on Enanta Pharma
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Enanta Pharma.
Analysts have given Enanta Pharma a total of 2 ratings, with the consensus rating ...